Generic Name: Deferasirox
Brand Name: Exjade
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Iron overload
Indications: Iron overload
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: April 19, 2007
Recommendation Type: List with clinical criteria and/or conditions